Omnicell
OMCL
295 hedge funds and large institutions have $3.04B invested in Omnicell in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 114 increasing their positions, 116 reducing their positions, and 43 closing their positions.
238% more call options, than puts
Call options by funds: $2.75M | Put options by funds: $812K
12% more capital invested
Capital invested by funds: $2.71B → $3.04B (+$331M)
3.83% more ownership
Funds ownership: 97.25% → 101.08% (+3.8%)
2% less repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 116
3% less funds holding
Funds holding: 305 → 295 (-10)
19% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 43
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$111M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$18.8M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$17.3M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$14.7M |
| 5 |
BlackRock
New York
|
+$11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$11.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$8.84M |
| 3 |
TCM
Tygh Capital Management
Portland,
Oregon
|
-$8.68M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.07M |
| 5 |
JP Morgan Chase
New York
|
-$6.82M |
OMCL Hedge Fund Activity: Q2 2020 in Review
295 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q2 2020, worth a combined $3.04B — up 12% from $2.71B a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of OMCL and 35 opened new positions — a net loss of 8 holders — while 116 trimmed existing stakes and 114 added.
The largest buyer was Wellington Management Group, adding an estimated $111M. The largest seller was Conestoga Capital Advisors, cutting an estimated $11.1M.
- 295 institutional investors held Omnicell (OMCL) as of Q2 2020, down from 305 in Q1 2020.
- Funds reported $3.04B of Omnicell stock for Q2 2020, up 12% quarter-over-quarter.
- 35 funds opened new Omnicell positions in Q2 2020 and 43 closed out, a net change of -8 holders.
- The largest Omnicell buyer in Q2 2020 was Wellington Management Group, an estimated $111M added.
- The largest Omnicell seller in Q2 2020 was Conestoga Capital Advisors, an estimated $11.1M sold.
Based on aggregated 13F filings for Q2 2020.